CONDENSED CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenue:
Total revenue	$ 80,992	$ 108,220	$ 157,364	$ 198,279
Expenses:
Selling, general and administrative	23,542	11,782	43,277	18,274
Research and development	14,989	13,884	27,577	19,722
Amortization of acquired intangible assets	4,958	0	8,763	0
Loss on extinguishment of debt	0	0	0	20,662
Changes in fair values of equity method investments, net	19,911	42,823	4,094	54,773
Changes in fair values of other equity and long-term investments, net	83	15,777	2,247	13,238
Interest and dividend income	(3,553)	(724)	(6,918)	(1,046)
Interest expense	4,382	3,655	8,809	6,665
Other expense, net	1,896	528	3,242	778
Total expenses	75,187	87,725	110,419	133,066
Income before income taxes	5,805	20,495	46,945	65,213
Income tax expense (benefit), net	4,525	(876)	10,800	5,984
Net income	1,280	21,371	36,145	59,229
Net income attributable to noncontrolling interests	0	20,432	0	42,517
Net income attributable to Innoviva stockholders	$ 1,280	$ 939	$ 36,145	$ 16,712
Basic net income per share attributable to Innoviva stockholders	$ 0.02	$ 0.01	$ 0.54	$ 0.24
Diluted net income per share attributable to Innoviva stockholders	$ 0.02	$ 0.05	$ 0.46	$ 0.24
Shares used to compute Innoviva basic and diluted net income per share:
Shares used to compute basic net income per share	65,341	69,643	66,557	69,594
Shares used to compute diluted net income per share	65,489	95,653	88,175	94,692
Royalty revenue
Revenue:
Total revenue	$ 62,265	$ 108,220	$ 119,123	$ 198,279
Net product sales
Revenue:
Total revenue	15,727	0	27,241	0
Expenses:
Cost of products sold (inclusive of amortization of inventory fair value adjustments, excluding depreciation and amortization of intangible assets)	8,979	0	17,728	0
License revenue
Revenue:
Total revenue	3,000	0	11,000	0
License
Expenses:
Cost of license revenue	$ 0	$ 0	$ 1,600	$ 0